About Kenay – PEA Palmitoiloetanoloamide Levagen+ 350 mg

Kenay PEA Palmitoiloetanoloamide Levagen+ delivers 350 mg of high-quality Palmitoylethanolamide (PEA) per capsule, utilising the branded Levagen®+ ingredient — a form of PEA produced to stringent quality standards. PEA is a naturally occurring fatty acid amide found in the body and in various food sources, making it a well-recognised compound of interest in the field of nutritional science.

What sets this formulation apart is the incorporation of LipiSperse® technology, an advanced dispersion system designed to enhance the solubility and bioavailability of lipophilic (fat-soluble) ingredients such as PEA. This means each capsule is optimised to support efficient absorption, helping you get the most from every daily serving.

Presented in convenient vegetarian Vcaps® capsules made from hydroxypropyl methylcellulose, this product is suitable for vegetarians and free from gelatin. With 60 capsules per pack — a full two-month supply at the recommended dose — Kenay PEA Levagen+ is a practical and high-quality addition to a balanced and varied diet.

Výživové údaje

Živina	Na jednu dávku (1 kapsula)
Palmitoylethanolamide (PEA) [Levagen®+]	350 mg

* Nie je stanovená žiadna denná referenčná hodnota.

Zložky

Palmitoylethanolamide (PEA); LipiSperse® technology (emulsifier: esters of fatty acids and polyglycerol; solvent: fractionated coconut oil; emulsifiers: mono- and diglycerides of fatty acids, sunflower lecithin; antioxidant: vitamin E acetate); anti-caking agent: silicon dioxide; capsule: hydroxypropyl methylcellulose.

Capsule shell: Hydroxypropyl methylcellulose (Vcaps® vegetarian capsule)

Spôsob použitia a dávkovanie

Take 1 capsule daily. Do not exceed the recommended daily dose.

Upozornenia

Do not exceed the recommended daily dose. Dietary supplements cannot be used as a substitute for a varied diet. Do not use in case of hypersensitivity to any ingredient of the preparation. The preparation should not be used by pregnant or breastfeeding women, or by children and adolescents under 18 years of age.